ADVANCING REGENERATIVE MEDICINE
Samumed is a leader in medical research and development for tissue-level regeneration. With our platform's origins in small molecule-based Wnt pathway modulation (See Technology), we develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.
STRIVING FOR NEW STANDARDS FOR THE BUSINESS OF LIFE SCIENCES
We adopt a novel approach to the business of life sciences, combining and balancing medical priorities, fiscal efficiency, and social responsibility. In doing so, we strive to reward our investors by approaching each program with urgency. We work with the necessary partners, advisors, and clinicians to develop high-quality medical solutions in all relevant jurisdictions.
UNIQUE FROM INCEPTION
Founded in San Diego, California in 2008, Samumed adopted a fresh operating philosophy from the beginning — one based on a goal of building a broad technology platform aimed at modulating regenerative pathways to improve patient health. As an independent and management-controlled company, Samumed has capitalized on the ability to execute a unique, long-term vision. Scientific innovation remains the cornerstone of our company as we discover and develop a diverse set of drug candidates. Our integrated approach begins in our lab, continues into clinical studies, and extends into commercialization (See Pipeline). As we make further progress in the clinic, we continue to invest in early-stage discovery and research capabilities, broadening not only our patent portfolio, but also the list of therapeutic applications in which our underlying know-how can be deployed to achieve significant clinical impact.